senior notes offering
PerkinElmer Prices Senior Notes Offering
The $2.3 billion offering will provide some of the money PerkinElmer needs to complete its planned acquisition of BioLegend.
Thermo Fisher Scientific Prices $3.1B Senior Notes Offering
The company plans to use the net proceeds from the offering to pay a portion of the cash price for the pending acquisition of PPD.
Sequencing Startup Singular Genomics Files for $100M IPO
The San Diego-based company, led by a raft of Illumina veterans, is planning to build a new sequencing platform to address genomic and multiomic analysis.
Illumina Prices $1B Senior Notes Offering
The sequencing instruments maker will use the proceeds to fund its planned acquisition of Grail and to pay related fees and expenses.
PerkinElmer to Offer $800M in Senior Notes
The firm plans to use $561 million of the net proceeds to fund the majority of its planned $591 million acquisition of Oxford Immunotec.
Mar 4, 2021
Agilent Prices $850M Senior Notes Offering
Nov 17, 2020
Guardant Health Prices $1B Senior Notes Offering
Sep 30, 2020
Danaher Prices $1B Senior Notes Offering
Sep 28, 2020
Hologic Completes $950M Senior Notes Offering
Sep 15, 2020
Hologic Prices $950M Offering of Senior Notes
May 8, 2020
Luminex Prices $260M Senior Notes Offering
Apr 14, 2020
Natera Prices $250M Senior Notes Offering
Mar 26, 2020